Rheumatoid arthritis (RA) is a systemic inflammatory disease in which the predominant
symptom is polyarthritis that follows a chronic and progressive clinical course characterized …

CLIN AND EXP RHEUM 25/6 Page 1 Clinical and Experimental Rheumatology 2007; 25:
810-816. A multicenter study of leukocytapheresis in rheumatoid arthritis Y. Ueki1, A. Sagawa2 …

Several clinical trials have demonstrated that leukocytapheresis (LCAP) is a safe and
effective therapy for patients with refractory rheumatoid arthritis (RA). However, most of those …

In this article, we discussed leukocytapheresis (LCAP) for rheumatoid arthritis (RA).
Recently, a simple and practical on-line continuous LACP system has been developed. It is …

Infliximab (INF), a tumor necrosis factor‐alpha (TNF‐α) inhibitor, is an effective drug for
patients with rheumatoid arthritis (RA). However, some patients receive no clinical benefit, or …

To evaluate the efficacy of high-dose leukocytapheresis (LCAP) using a large filter in
patients with refractory rheumatoid arthritis (RA), we conducted a multicenter …

Several clinical trials revealed that leukocytapheresis (LCAP) was safe and effective therapy
for patients with rheumatoid arthritis (RA). In this article, the mechanism of the efficiency of …

Leukocytapheresis (LCAP) has recently been investigated for the treatment of drug‐resistant
rheumatoid arthritis (RA). In the present clinical study, we used LCAP in three patients with …

Objective To determine the efficacy and safety of filtration leukocytapheresis (LCP) for the
treatment of rheumatoid arthritis (RA). Methods Twenty‐five patients with drug‐resistant RA …

We evaluated the relationship between the clinical benefit of filtration leukocytapheresis
(LCP) and the number of removed leukocytes in patients with rheumatoid arthritis (RA). LCP …